Flurbiprofen
- Generic Name
- Flurbiprofen
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13FO2
- CAS Number
- 5104-49-4
- Unique Ingredient Identifier
- 5GRO578KLP
- Background
Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or red...
- Indication
Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be use...
- Associated Conditions
- Ankylosing Spondylitis (AS), Back Pain, Acute, Chronic Back Pain, Menstrual Distress (Dysmenorrhea), Muscle Spasms, Non-Articular Rheumatic Muscle Spasms, Osteoarthritis (OA), Pain, Pain, Inflammatory, Post Traumatic Pain, Postoperative pain, Rheumatoid Arthritis, Spinal pain
- Associated Therapies
- -
Oral Flurbiprofen Spray for Mucosal Graft Harvesting at the Palatal Area
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Gazi University
- Target Recruit Count
- 48
- Registration Number
- NCT03165929
Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2017-12-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 26
- Registration Number
- NCT03131973
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs
- Conditions
- Interventions
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- Polak David
- Target Recruit Count
- 100
- Registration Number
- NCT03090009
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering
- Conditions
- Interventions
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2015-10-27
- Lead Sponsor
- Guangxi Medical University
- Target Recruit Count
- 166
- Registration Number
- NCT02569905
- Locations
- 🇨🇳
Anesthesia Department, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 20
- Registration Number
- NCT02227173
- Locations
- 🇺🇸
Healthcare Discoveries, LLC d/b/a ICON Development Solutions, San Antonio, Texas, United States
Comparison of Two Kinds of Postoperative Analgesia After Amputation
- Conditions
- Interventions
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2015-03-12
- Target Recruit Count
- 36
- Registration Number
- NCT02114463
- Locations
- 🇨🇳
Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou, Guangdong, China
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 122
- Registration Number
- NCT01986361
- Locations
- 🇺🇸
University of Connecticut - Student Health Services, Storrs, Connecticut, United States
A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis
- Conditions
- Interventions
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 198
- Registration Number
- NCT01048866
- Locations
- 🇺🇸
Bluestone Center for Clinical Research, New York, New York, United States
A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 204
- Registration Number
- NCT01049334
- Locations
- 🇺🇸
University of Connecticut, Student Health Services, Storrs, Connecticut, United States
The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Dexcel Pharma Technologies Ltd.
- Registration Number
- NCT01040286
- Locations
- 🇮🇱
Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center, Haifa, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.